retatrutide trial duration How Long Will 10mg of Last? retatrutide trial results news Retatrutide,

These two systems are inseparable, because the dose changes every four weeks and each change means a different number of syringe units

Wegovy The drug was originally used to treat diabetes

The study population had a mean age of 54 years and a mean BMI of 36.1 kg/m 2 and experienced a BW reduction of 12.8%, 14.7% and 3.2% with tirzepatide 10 mg, tirzepatide 15 mg and placebo, respectively, at 72 weeks 37

A phase 3b open-label randomized clinical trial (SURMOUNT-5) has shown that tirzepatide leads to greater weight reduction compared to semaglutide in adults with obesity or overweight conditions

Dutta D et al (2021) Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis